Associations between sarcopenic obesity subtypes, cognitive function and neurodegenerative diseases risk in middle-aged and older adults.
Key claim: Sarcopenic obesity comprises distinct phenotypic subtypes, with a covert sarcopenia and muscle strength imbalance subtype conferring greater cognitive impairment than metabolic burden alone.
Abstract
PURPOSE/AIMS: This study aimed to identify subtypes of sarcopenic obesity (SO) in middle-aged and older adults and examine their associations with cognitive function and the risk of incident neurodegenerative diseases (NDs), to inform subtype-specific screening. METHODS: We utilized data from the China Health and Retirement Longitudinal Study (CHARLS), with baseline in 2011 and follow-up through 2020, incorporating 1,010 middle-aged and older adults with SO. Latent class analysis (LCA) was used to identify SO subtypes. Cross-sectional associations of subtypes and cognitive function were examined using linear regression models, and Cox proportional hazards models were applied to evaluate association with incident NDs. RESULTS: Three SO subtypes were identified: Covert sarcopenia-muscle strength imbalance (CS-MSI), Low metabolic burden-muscle maintenance (LMB-MM), and High metabolic burden-inflammation driven (HMB-ID). Compared with LMB-MM, the CS-MSI subtype had lower performance across multiple cognitive domains, whereas the HMB-ID subtype showed a comparatively prominent decrement in orientation (β = -1.12, 95% CI: -1.66 to -0.58). Longitudinally, the CS-MSI subtype showed a directionally higher but non-significant hazard of incident NDs. CONCLUSIONS: Distinct SO subtypes were associated with different cognitive profiles. Recognizing the CS-MSI subtype, which conventional obesity- and metabolism-based screening would miss, may improve early identification of middle-aged and older adults at risk, pending validation in independent cohorts.
Why this matters
[human-observational] This CHARLS analysis associates distinct sarcopenic-obesity phenotypes with different cognitive profiles, with poorer multi-domain performance in the covert-sarcopenia and muscle-strength-imbalance subtype than in high-metabolic-burden phenotypes. [human-observational] The finding extends the muscle-function–cognition association but leaves reverse causation and residual confounding unresolved; it does not establish that improving strength prevents cognitive decline or identify an effective training protocol.